[Topical administration of corticosteroids and their adverse effects].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003480:Cushing Syndrome / Q000139:chemically induced; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004361:Drug Tolerance; D006801:Humans; D006854:Hydrocortisone; D010592:Pharmaceutic Aids; D010859:Pigmentation Disorders / Q000139:chemically induced; D012869:Skin Absorption / Q000187:drug effects; D013684:Telangiectasis / Q000139:chemically induced
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000893:Anti-Inflammatory Agents; D010592:Pharmaceutic Aids; D006854:Hydrocortisone; D004121:Dimethyl Sulfoxide
Uber die perkutane Anwendung der Kortikosteroide und ihre Nebenwirkungen.